The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis
Susan Cleator(Imperial College Healthcare NHS Trust), Mitch Dowsett(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Ian E. Smith(Papworth Hospital), Alan Ashworth(University of California, San Francisco), Trevor J. Powles(Royal Marsden NHS Foundation Trust), Haukur Valgeirsson(Institute of Cancer Research), Tim Dexter(Institute of Cancer Research), Laura Fulford(Institute of Cancer Research)
Cited by 71
Related Papers
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
|The Lancet|2007|1.5k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k